Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s368584 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Khaled M Musallam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: beta-Thalassemia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thalassemia Center, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
- Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
- First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
- Division of Hematology, University of Toronto, Toronto, ON, Canada.
- Division of Hematology and Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA.
- Department of Clinical Sciences and Community, University of Milan, Ca' Granda Foundation IRCCS Maggiore Policlinico Hospital, Milan, Italy.
ORCID-Profile: Khaled M Musallam, Ali T Taher, Antonis Kattamis, Kevin H M Kuo, Sujit Sheth, Maria Domenica Cappellini
Zitieren
APA
Musallam, K. M., Taher, A. T., Kattamis, A., Kuo, K. H. M., Sheth, S., & Cappellini, M. D. (2023). Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s368584
Vancouver
Musallam KM, Taher AT, Kattamis A, Kuo KHM, Sheth S, Cappellini MD. Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s368584
BibTeX
@article{Musallam2023,
author = {Musallam, Khaled M and Taher, Ali T and Kattamis, Antonis and Kuo, Kevin H M and Sheth, Sujit and Cappellini, Maria Domenica},
title = {Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s368584}
}
EUVIMED